Lotus Pharmaceuticals, Inc. Announces Certain Clarification to its Annual Report on Form 10-K for the year ended December 31, 2008 and Quarterly Report for the Quarter ended June 30, 2009
BEIJING, Nov. 5 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic of China, today announced correction to ...
Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy
BEIJING, Oct. 20 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic of China, today announced its 2010 gr...
Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
BEIJING, Aug. 14 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic China, today reported its financial r...
Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
BEIJING, July 30 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic of China, today reported it received no...
Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification
BEIJING, June 29 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic of China, today reported it received a ...
Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
BEIJING, May 19 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a company that controls and operates pharmaceutical companies in the People's Republic of China ("PRC"), today reported its financial results for the first quarter ended Mar...
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
Expands Into Inner Mongolia to Fuel Future Growth BEIJING, April 23 /PRNewswire-Asia/ -- -- Revenues of $73.8 million -- Gross Profit of $33.4 million -- Net income of $12.8 million or $0.27 per diluted share Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS, "Lotu...
Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
BEIJING, Feb. 5 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical products developer, manufacturer and distributor in the People’s Republic of China, today announced that its contractually controlled subsidiary Beijing Liang ...
Lotus Pharmaceuticals Announces Third Quarter 2008 Results
BEIJING, Nov. 18 /PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a company that controls and operates pharmaceutical companies in the People's Republic of China ("PRC"), today announced financial results for the quarter and nine mo...
Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2008 Results
BEIJING, Nov. 15 /Xinhua-PRNewswire/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 9:00 a.m. Eastern Standard Time on Tuesday, Nov...
Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
BEIJING, Nov. 5 /Xinhua-PRNewswire/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced that it will present at the upcoming Rodman & Renshaw Global Investment Conference taking ...
Lotus Pharmaceuticals, Inc.'s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
BEIJING, Sept. 26 /Xinhua-PRNewswire/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical products developer, manufacturer and distributor in the People's Republic of China ("PRC"), today announced that China's State Food and Drug Administration...
Lotus Pharmaceuticals Announces Second Quarter 2008 Results
BEIJING, Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People’s Republic of China ("PRC"), today announced financial results for the quarter and six months ended June 30, 2008. Se...
Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
BEIJING, Aug. 14 /Xinhua-PRNewswire/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People’s Republic of China ("PRC"), today announced that it will conduct a conference call at 10:00 a.m. Eastern Time on Monday, August 18, 2...
Lotus Pharmaceuticals Acquires New Manufacturing Site and Plans New Products
BEIJING, July 28 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced that on June 3, 2008 it entered into an agreement with the Cha You Qian Qi ...
Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
BEIJING, May 30 /Xinhua-PRNewswire/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today reiterates its confidence in meeting the "make good" earnings target of net income $13.1 million for...
Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
BEIJING, May 27 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (“Lotus” or the “Company”), a pharmaceutical company in the People’s Republic of China ("PRC"), today announced that it will conduct a conference call at 10:00 a.m. Eastern Time on Tuesday, ...
Lotus Pharmaceuticals, Inc. Announces First Quarter 2008 Results
BEIJING, May 22 /Xinhua-PRNewswire/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced financial results for the first quarter ended March 31, 2008. First Quarter 2008 Hi...
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
BEIJING, April 25 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced the resignation of Mel Rothberg from the Company's board of directors, effec...
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
BEIJING, April 17 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (“Lotus” or the “Company”), a pharmaceutical company in the People’s Republic of China ("PRC"), today announced financial results for the fourth quarter and fiscal year ended December 31, ...
